ArticleAnnals of medicine and surgery (2012)2026
Artificial intelligence in genomics: improving detection of fusion genes in soft tissue sarcomas.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The integration of artificial intelligence (AI) into clinical workflows for soft tissue sarcomas (STS) marks a major step forward in precision oncology. As diagnostic complexity grows, AI-driven genomics - particularly in detecting fusion genes - enhances sensitivity, speed, and accuracy, improving patient stratification and guiding targeted therapies. The convergence of AI with multi-omic datasets, including transcriptomic, epigenomic, and imaging data, offers a holistic view of sarcoma biology, enabling earlier detection and more personalized treatment. Achieving these benefits, however, requires global collaboration, standardized protocols, and continuous clinician education. Ultimately, AI's transformative potential in STS management depends not only on technological innovation but also on the establishment of robust frameworks for its clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.